Skip to content

Clinical research and objective evaluation of the superior effect intervention of the non-drug characteristic treatment of chronic fatigue syndrome

Clinical research and objective evaluation of the superior effect intervention of the non-drug characteristic treatment of chronic fatigue syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003947
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic fatigue syndrome

Interventions

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: According to the CFS diagnostic criteria established by the Centers for Disease Control and Prevention (CDC) in 1994, it meets the a) Long-term or recurrent fatigue, lasting more than 6 months; b) According to medical history, physical signs or laboratory test results, various organic diseases that cause chronic fatigue can be ruled out. And have at least 4 of the following 8 items at the same time: 1) Short-term memory loss or inability to concentrate; 2) Sore throat; 3) Pain in lymph nodes; 4) Muscle aches; 5) Joint pain without redness and swelling; 6) New headache; 7) The energy cannot be recovered after sleep; 8) Consecutive 24 hours of physical discomfort after physical or mental work.

Exclusion criteria

Exclusion criteria: Subjects who meet any of the following will not be included in the group: 1) There is no chief complaint of fatigue, or fewer than 4 accompanying symptoms; 2) The fatigue symptoms can be relieved after rest; 3) The fatigue symptoms do not cause a substantial decrease in work ability, ability to receive education, social activities and entertainment activities, and personal life ability; 4) Suffer from tumor, diabetes, rheumatism and other diseases that can clearly cause fatigue; 5) Patients with severe heart, lung, liver, and kidney function abnormalities, and patients with abnormal thyroid function; 6) Patients with mental illness; 7) Women during pregnancy and lactation; 8) Adopt drug and non-drug treatment within 7 days before enrollment; 9) At the same time participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Child Fatigue Scale;

Secondary

MeasureTime frame
Interleukin;Tumor necrosis factor-a;Quality of life scale;C reactive protein;Brief Profile Of Mood States;Blood immunoglobulin;Blood cortisol;Pittsburgh Sleep Quality Index;gamma interferon;Blood lactic acid;

Countries

China

Contacts

Public ContactMin Fang

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Chinese Medicine

fm-tn0510@shutcm.edu.cn+86 18930568005

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026